Reconsidering Ibogaine for the treatment of severe mental illness and substance use disorders
Journal of Medicine Surgery and Public Health August 25, 2025 R. Andrew Yockey 2 citations
Severe mental illness (SMI) and co-occurring substance use disorders (SUDs) continue to pose a major global health challenge, contributing to high rates of mortality, disability, and economic strain. Ibogaine, a naturally occurring psychoactive compound derived from the Tabernanthe iboga plant, has shown promise in easing withdrawal symptoms, reducing cravings, and improving psychiatric...
DOI: 10.1016/j.glmedi.2025.100213 (opens in new tab)
Mental illness
Substance use
Psychotherapist
Mental health